INTRODUCTION {#sec1-1}
============

Post-operative fever is a common complication of cardiac operations using cardiopulmonary bypass (CBP). Frequency of post-operative fever in cardiovascular surgery varies from 12% to 73% in studies of adults and children. In cardiovascular surgery, this type of fever has generally been related with the use of CPB and the post-perfusion syndrome, as well as infections, blood transfusions, dehydration and atelectasis.[@ref1][@ref2] Post-operative fever is known to be correlated with a greater degree of cognitive dysfunction 6 weeks after cardiac surgery.[@ref3][@ref4]

Induced hypothermia is the only reliable method of neuroprotection from injuries related to cerebral ischemia from any cause.[@ref5] However, several studies have failed to confirm the putative protective effect of hypothermia during cardiac surgeries.[@ref5][@ref6] Possible explanations for this may be due to the well-known inflammatory response to CPB and damage occurring during the re-warming process.[@ref6][@ref7]

Post-operative fever reflect an inflammatory response initiated either in response to the surgical trauma itself or to the interaction of blood with the foreign surfaces of the CPB circuit.[@ref8] In cardiac surgery, cytokines such as TNF-a, IL-1b and IL-6 are also known to be elevated both during and after surgery in a manner consistent with other markers of cellular injury and inflammatory stimuli.[@ref9][@ref10] Alternatively, fever may be a marker of cerebral injury with altered function of the thermoregulatory centre in the hypothalamus.[@ref11][@ref12]

Paracetamol is a synthetic, non-opioid, centrally acting analgesic and antipyretic agent. Its effectiveness as an antipyretic agent has been attributed to its effect on the hypothalamic heat regulating centre. It has a well-established efficacy profile, a well understood risk/benefit ratio and a very low potential for harmful drug interactions. In recommended doses, Paracetamol is considered safe for all age strata, from infants to the elderly.[@ref13] Several studies have examined intravenous Paracetamol effect on pain[@ref14][@ref15] and lately a systematic review of the analgesic effect of Paracetamol has confirmed its efficacy and safety as an analgesic agent in post-operative pain treatment.[@ref16] However, evidences regarding Paracetamol antipyretic effect, especially on post-operative fever are not sufficient.

The aim of the present randomised, double-blind, placebo-controlled clinical study was to examine the efficacy and safety of single dose of intravenous Paracetamol in treatment of post-operative fever in children undergoing cardiac surgery.

MATERIALS AND METHODS {#sec1-2}
=====================

During the present double-blind randomised, placebo-controlled clinical trial (IRCT201207215506N6), which was performed in Educational-Medical centres of Tabriz University of Medical Sciences (Tabriz, Iran) between September 2010 and September 2012, 80 children, aged 1-12 years, presenting for open cardiac surgery were entered in the trial after written informed parental consent and verbal child assent had been obtained. Using a computer-generated random table, a hospital nurse allocated children into two groups: Placebo and Paracetamol. Both the patients and investigators were blinded to the study group assignment. Exclusion criteria were history of previous sensitivity to Paracetamol, liver and kidney disease.

Demographic characteristics consisted of vital signs and axillary temperature of the participants were measured and recorded exactly before the anaesthesia induction. After induction of anaesthesia, 15 mg/kg intravenous Paracetamol solution was infused during 1 h in the Paracetamol group. Patients in placebo group received 15 mg/kg normal saline infusion during the same time. Since the end of operation until next 24 h in intensive care unit (ICU), axillary temperature of the two group patients was recorded in 4-h intervals. The fever was defined based on axillary temperature more than 37.2°C. Any fever occurred during this period had been treated with Paracetamol suppository (125 mg) and the amount of antipyretic drug consumption for each patient had been recorded. In order to examine the safety of Paracetamol, patients were evaluated for drug complication (systolic blood pressure (SBG) below 90 mmHg, dyspnoea, skin rash, anaphylactic shock and thrombocytopenia) at the same time.

Induction of anaesthesia was done by fentanyl 10 μg/kg, intravenously, and in children with haemodynamic stability thiopental 4 mg/kg, intravenously, followed by pancuronium 0.1 mg/kg intravenously. Sevoflurane inhalation for children without intravenous access with 7% concentration and after intravenous access was used. According to pre-operative status and response to induction of anaesthesia and tolerance of individual patient, maintenance of anaesthesia was done. Maintenance of anaesthesia was achieved by sevoflurane and fentanyl 2 μg/kg/h intravenous bolus. After induction of anaesthesia and securing of the airway, arterial and central venous lines are placed. Standard monitoring includes electrocardiogram (ECG), pulse oxymetery, capnography, blood pressure (BP), central venous pressure, temperature, urine out-put and airway volume and pressure. During CBP, anaesthesia was maintained with intravenous narcotic, muscle relaxant and benzodiacepine. After successful weaning from CBP, maintenance anaesthesia was preferred to with fentanyl and a small amount of sevoflurane because the minimal myocardial depression was associated with these agents. In most children with uncomplicated defects, endotracheal extubation was performed early in the ICU.

The primary outcome variables were incidence of fever and mean temperature increase during the first 24 h post-operatively. Secondary outcome variables were need for antipyretic consumption and incidence of complications (dyspnoea and thrombocytopenia, decrease in SBG, anaphylactic shock and skin rash) in the first 24 h post-operatively. The data were collected by the ICU nurses and subsequently validated by the review of clinical notes.

Statistical analysis was performed by SPSS software package version 16.0 for Windows (SPSS Inc., Chicago, USA). Quantitative data were presented as mean ± standard deviation (SD), while qualitative data were demonstrated as frequency and percent (%). For statistical analysis, collected data were studied using descriptive statistical methods, the mean difference test for independent groups, chi-square test or Fisher\'s exact test. One way analysis of variance (ANOVA) test was used to compare groups. However, repeated measurements of ANOVA were used to compare post-operative axillary temperature levels in both groups. *P* value less than 0.05 was statistically considered significant in all steps. The study protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences (TUMS), which was in compliance with Helsinki Declaration.

RESULTS {#sec1-3}
=======

Eighty children recruited based on inclusion criteria and divided randomly in two groups of Paracetamol (*N* = 40) and placebo (*N* = 40). The patients and surgical characteristics were comparable across the groups \[[Table 1](#T1){ref-type="table"}\]. There were no significant differences in pre-operative vital signs including heart rate (HR), respiratory rate (RR), axillary temperature, SBP and diastolic blood pressure (DBP) between two groups \[[Table 1](#T1){ref-type="table"}\].

###### 

Patient characteristics and pre-operative vital signs of study groups
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Mean axillary temperature during first 24 h after operation was significantly lower in Paracetamol group compared with placebo group (37.57 ± 0.53 Vs. 37.80 ± 0.60, respectively, *P* = 0.001) \[[Figure 1](#F1){ref-type="fig"} and [Table 2](#T2){ref-type="table"}\].
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Post-operative mean axillary temperature in study groups
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Overall fever (axillary temperature more than 37.2°C) incidence during 24 h after operation was higher in placebo group compared with Paracetamol group and this difference was significant in mean temperature measured 4 h after surgery (*P* = 0.012) \[[Table 3](#T3){ref-type="table"}\].
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Fever incidence during 24 h after operation in study groups
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Seventeen (42.5%) patients of Paracetamol group compared with six (15.0%) of placebo group participants had no consumption of antipyretic agent (Paracetamol suppository) during 24 h after operation (*P* = 0.001).

None of the patients in both groups had dyspnoea, skin rash, anaphylactic shock and thrombocytopenia in 24 h after operation. Similarly two of the children in each group had SBP below normal range, based on their age in 24 h after operation, but none of them need further intervention.

DISCUSSION {#sec1-4}
==========

This trial attempted to study the antipyretic effect of intravenous Paracetamol on post-operative fever in paediatric cardiac surgery and compare it with placebo in a randomised manner. Our data showed that mean axillary temperature during first 24 h after operation was significantly lower in Paracetamol group compared with placebo group. Despite this, there was no significant difference, overall fever incidence in the same time was higher in placebo group compared with Paracetamol group. In contrast, compared with the placebo group, patients receiving Paracetamol had fewer post-operative fever rate and body temperature rise. The present study assumes that Paracetamol reduces body temperature by two possible mechanisms; blocking production of inflammatory chemicals and lowering the hypothalamic set-point in the thermoregulatory centre of brain.

Duhamel *et al*., in a study on 67 fevered 1-month-old to 12-year-old children, compared antipyretic effect of 15 mg/kg intravenous Paracetamol and 30 mg/kg intravenous Paracetamol and finally stated that while any of two drugs had dominance on the other one in terms of fever decrease but prescribing Paracetamol was safer for this age group.[@ref17]

In a study comparing antipyretic effect of 15 mg/kg Paracetamol and 10 mg/kg Ibuprofen on 3-month-old to 12-year-old children with fever of unknown origin, Ibuprofen was more successful in decreasing fever.[@ref18]

Schuitmaker *et al*., in a study compared the effect of rectal 15 mg/kg Paracetamol and nasogastric in decreasing post-operative fever in 9-day-old to 7-year-old children who had undergone heart surgery, and finally no significant difference between two methods was observed.[@ref19]

There are numerous studies examining antipyretic effects of Paracetamol in different clinical settings in literature, for example Kett *et al*., evaluated the antipyretic effect and safety of intravenous Paracetamol using an endotoxin-induced fever model, which shows that intravenous Paracetamol in a single 1000-mg dose, is safe and effective in reducing fever.[@ref13]

In another study on 210 febrile children (6 months to 6 years) with uncomplicated respiratory tract infection received oral Paracetamol (15 mg/kg) or placebo, Paracetamol achieves effective antipyretic and provides early symptomatic improvement in children with febrile illness without prolongation of fever duration or excessive adverse effects.[@ref20] These studies similarly suggest Paracetamol as an effective and safe antipyretic medication and not only are the same as our findings but also could be supportive of our assumption.[@ref20][@ref21]

Various studies have assessed Paracetamol in clinical surgical conditions as an analgesic agent for post-operative pain[@ref22][@ref23][@ref24] but as far as we know, studies regarding antipyretic effect of Paracetamol on post-operative fever are not sufficient, especially in paediatric cardiac surgery, thus our study could be one of the first randomised clinical trials evaluating Paracetamol effect in paediatrics cardiac operation.

There was potential limitation for this study due to axillary measuring of temperature. Axillary temperature is not a reliable representative of body core temperature and is technique dependent or can vary by peripheral body circulation alterations. Therefore it could be suggested to design a study by use of rectal or nasal temperature. Another limitation was that, surgery duration was different in each individual, which could affect post-operative body temperature alterations. In order to minimise these limitations, all the temperature measurements were done just by one specific nurse and different types of surgeries were randomly and equally distributed in both Paracetamol and placebo groups.

CONCLUSION {#sec1-5}
==========

In conclusion, this study suggests that single dose administration of intravenous Paracetamol before paediatric cardiac surgeries using CBP; limits mean body temperature rise in the first 24 h after operation.

**Source of Support:** Tabriz University of Medical Sciences

**Conflict of Interest:** None declared.
